Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
Amiodarone exhibits varying adverse drug reactions and onset times across different routes of administration. Clinicians should carefully consider these differences when selecting the administration route to balance the risks of adverse reactions with therapeutic benefits.
Authors
- Jing-Chao Sun (ORCID: https://orcid.org/0000-0002-6536-3449)
- Ricky Sun (ORCID: https://orcid.org/0009-0004-3025-4500)
- Lili Han (ORCID: https://orcid.org/0000-0003-3222-1580)
- Wenge Su
- Mengfan You
- Yifei Wang (ORCID: https://orcid.org/0000-0002-8873-613X)
- Xiaonan Liu (ORCID: https://orcid.org/0000-0002-0069-1257)
- Kaibin Niu
- Jingrong Yang (ORCID: https://orcid.org/0000-0003-1061-560X)
- Kaidi Xing
- Jingxin Wang
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Shanghai Public Health Clinical Center (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.3389/fphar.2025.1517616
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39